An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 022234
Company: HOSPIRA INC

Summary Review

Products on NDA 022234

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	AP	Yes	Yes
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	AP	Yes	Yes
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	AP	Yes	Yes
DOCETAXEL	DOCETAXEL	20MG/ML (20MG/ML)	INJECTABLE;INJECTION	Prescription	None	Yes	No
DOCETAXEL	DOCETAXEL	80MG/4ML (20MG/ML)	INJECTABLE;INJECTION	Prescription	None	Yes	No
DOCETAXEL	DOCETAXEL	120MG/6ML (20MG/ML)	INJECTABLE;INJECTION	Discontinued	None	Yes	No
DOCETAXEL	DOCETAXEL	160MG/8ML (20MG/ML)	INJECTABLE;INJECTION	Prescription	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 022234

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/08/2011	ORIG-1	Approval	Type 5 - New Formulation or New Manufacturer	STANDARD	Label (PDF) Letter (PDF) Letter (PDF) Review Summary Review (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022234s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/022234s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2011/022234s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022234_docetaxel_toc.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/022234Orig1s000SumR.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
05/15/2023	SUPPL-22	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022234s022lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/022234Orig1s022ltr.pdf
11/24/2020	SUPPL-18	Labeling-Patient Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022234s018lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/022234Orig1s018ltr.pdf
10/11/2019	SUPPL-15	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022234s012s013s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022234Orig1s012, s013, s015ltr.pdf
10/11/2019	SUPPL-13	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022234s012s013s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022234Orig1s012, s013, s015ltr.pdf
10/11/2019	SUPPL-12	Labeling-Patient Package Insert, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022234s012s013s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/022234Orig1s012, s013, s015ltr.pdf
09/24/2018	SUPPL-11	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022234s011,202356s003lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022234Orig1s011,202356Orig1s003ltr.pdf
08/02/2018	SUPPL-10		Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022234Orig1s010Lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/022234Orig1s010Ltr.pdf
09/27/2017	SUPPL-8	Labeling-Patient Package Insert, Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022234s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/022234Orig1s008ltr.pdf
01/25/2017	SUPPL-5	Manufacturing (CMC)	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022234s005lbl.pdf
06/24/2016	SUPPL-4	Manufacturing (CMC)		Label is not available on this site.
07/10/2014	SUPPL-3	Efficacy-New Indication	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022234s03lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/022234Orig1s003ltr.pdf
01/23/2014	SUPPL-2	Manufacturing (CMC)		Label is not available on this site.

Labels for NDA 022234

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
05/15/2023	SUPPL-22	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/022234s022lbl.pdf
11/24/2020	SUPPL-18	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/022234s018lbl.pdf
10/11/2019	SUPPL-15	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022234s012s013s015lbl.pdf
10/11/2019	SUPPL-13	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022234s012s013s015lbl.pdf
10/11/2019	SUPPL-12	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022234s012s013s015lbl.pdf
10/11/2019	SUPPL-12	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/022234s012s013s015lbl.pdf
09/24/2018	SUPPL-11	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022234s011,202356s003lbl.pdf
08/02/2018	SUPPL-10	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/022234Orig1s010Lbl.pdf
09/27/2017	SUPPL-8	Labeling-Patient Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022234s008lbl.pdf
09/27/2017	SUPPL-8	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022234s008lbl.pdf
01/25/2017	SUPPL-5	Manufacturing (CMC)	Label (PDF)	This supplement type does not usually require new labeling.	https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/022234s005lbl.pdf
07/10/2014	SUPPL-3	Efficacy-New Indication	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/022234s03lbl.pdf
03/08/2011	ORIG-1	Approval	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2011/022234s000lbl.pdf

Therapeutic Equivalents for NDA 022234

DOCETAXEL

INJECTABLE;INJECTION; 20MG/2ML (10MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	215744	ALEMBIC
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	214575	EUGIA PHARMA
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	213510	GLAND PHARMA LTD
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	Yes	AP	022234	HOSPIRA INC
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	209634	MEITHEAL
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	210072	MYLAN LABS LTD
DOCETAXEL	DOCETAXEL	20MG/2ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	201525	SANDOZ

INJECTABLE;INJECTION; 80MG/8ML (10MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	215744	ALEMBIC
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	214575	EUGIA PHARMA
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	213510	GLAND PHARMA LTD
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	Yes	AP	022234	HOSPIRA INC
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	209634	MEITHEAL
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	210848	MYLAN LABS LTD
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	207563	NOVAST LABS
DOCETAXEL	DOCETAXEL	80MG/8ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	201525	SANDOZ

INJECTABLE;INJECTION; 160MG/16ML (10MG/ML)
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	215744	ALEMBIC
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	214575	EUGIA PHARMA
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	213510	GLAND PHARMA LTD
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	Yes	AP	022234	HOSPIRA INC
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	209634	MEITHEAL
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	208859	MYLAN LABS LTD
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	207563	NOVAST LABS
DOCETAXEL	DOCETAXEL	160MG/16ML (10MG/ML)	INJECTABLE;INJECTION	Prescription	No	AP	201525	SANDOZ

Top